Targeting survival pathways to create infarct-spanning bridges of human embryonic stem cell-derived cardiomyocytes

Journal of Thoracic and Cardiovascular Surgery

Volumn 148, Issue 6, 2014, Pages 3180-3188.e1

  Luo, Jun ^a   Weaver, Matthew S ^a   Dennis, James E ^a   Whalen, Elizabeth ^a   Laflamme, Michael A ^b   Allen, Margaret D ^a,b  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPROTECTIVE AGENT; HEME OXYGENASE 1; PHOSPHATE BUFFERED SALINE; PROTOPORPHYRIN COBALT; HEME OXYGENASE; HMOX1 PROTEIN, RAT; PROTOPORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CELL PROLIFERATION; CELL THERAPY; CONTROL GROUP; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EMBRYONIC STEM CELL; FISCHER 344 RAT; GRAFT SURVIVAL; HEART INFARCTION; HEART MUSCLE; HEART VENTRICLE FUNCTION; HUMAN; HUMAN CELL; MORPHOMETRICS; NONHUMAN; RAT; SURVIVAL; ANIMAL; CELL DIFFERENTIATION; CELL LINE; CELL PROTECTION; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECTS; HEART CONTRACTION; HEART MUSCLE CELL; METABOLISM; MOLECULARLY TARGETED THERAPY; MYOCARDIAL INFARCTION; NUDE RAT; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; TIME; TRANSPLANTATION; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CYTOPROTECTION; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; GRAFT SURVIVAL; HEME OXYGENASE (DECYCLIZING); HUMANS; MOLECULAR TARGETED THERAPY; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; PROTOPORPHYRINS; RATS, NUDE; SIGNAL TRANSDUCTION; TIME FACTORS; UP-REGULATION; VENTRICULAR FUNCTION;

EID: 84920025576     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2014.06.087     Document Type: Article

References (35)

1. F. Torrent-Guasp, M. Ballester, G.D. Buckberg, F. Carreras, A. Flotats, and I. Carrio Spatial orientation of the ventricular muscle band: physiologic contribution and surgical implications J Thorac Cardiovasc Surg 122 2001 389 392
2. G. Buckberg, A. Mahajan, S. Saleh, J.I. Hoffman, and C. Coghlan Structure and function relationships of the helical ventricular myocardial band J Thorac Cardiovasc Surg 136 2008 578 589 589.e1-11
3. G.D. Buckberg Basic science review: the helix and the heart J Thorac Cardiovasc Surg 124 2002 863 883
4. H.M. Spotnitz Macro design, structure, and mechanics of the left ventricle J Thorac Cardiovasc Surg 119 2000 1053 1077
5. M. Zhang, D. Methot, V. Poppa, Y. Fujio, K. Walsh, and C.E. Murry Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies J Mol Cell Cardiol 33 2001 907 921
6. T.E. Robey, M.K. Saiget, H. Reinecke, and C.E. Murry Systems approaches to preventing transplanted cell death in cardiac repair J Mol Cell Cardiol 45 2008 567 581
7. I. Chimenti, R.R. Smith, T.S. Li, G. Gerstenblith, E. Messina, and A. Giacomello Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice Circ Res 106 2010 971 980
8. J.V. Terrovitis, R.R. Smith, and E. Marban Assessment and optimization of cell engraftment after transplantation into the heart Circ Res 106 2010 479 494
9. R.K. Li, D.A. Mickle, R.D. Weisel, V. Rao, and Z.Q. Jia Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury Ann Thorac Surg 72 2001 1957 1963
10. M.A. Laflamme, K.Y. Chen, A.V. Naumova, V. Muskheli, J.A. Fugate, and S.K. Dupras Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts Nat Biotechnol 25 2007 1015 1024
11. S.T. Lee, A.J. White, S. Matsushita, K. Malliaras, C. Steenbergen, and Y. Zhang Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction J Am Coll Cardiol 57 2011 455 465
12. J. Luo, M.S. Weaver, B. Cao, J.E. Dennis, B. Van Biber, and M.A. Laflamme Cobalt protoporphyrin pretreatment protects human embryonic stem cell-derived cardiomyocytes from hypoxia/reoxygenation injury in vitro and increases graft size and vascularization in vivo Stem Cells Trans Med 3 2014 734 744
13. S. Kawamoto, J.P. Flynn, Q. Shi, S.W. Sakr, J. Luo, and M.D. Allen Heme oxygenase-1 induction enhances cell survival and restores contractility to unvascularized three-dimensional adult cardiomyocyte grafts implanted in vivo Tissue Eng Part A 17 2011 1605 1614
14. C.A. Piantadosi, M.S. Carraway, A. Babiker, and H.B. Suliman Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1 Circ Res 103 2008 1232 1240
15. C. Cai, L. Teng, D. Vu, J.Q. He, Y. Guo, and Q. Li The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release J Biol Chem 287 2012 33720 33732
16. L.G. Melo, R. Agrawal, L. Zhang, M. Rezvani, A.A. Mangi, and A. Ehsan Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene Circulation 105 2002 602 607
17. Y.L. Tang, K. Qian, Y.C. Zhang, L. Shen, and M.I. Phillips A vigilant, hypoxia-regulated heme oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivo J Cardiovasc Pharmacol Ther 10 2005 251 263
18. S.F. Yet, R. Tian, M.D. Layne, Z.Y. Wang, K. Maemura, and M. Solovyeva Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice Circ Res 89 2001 168 173
19. X. Liu, J.A. Simpson, K.R. Brunt, C.A. Ward, S.R. Hall, and R.T. Kinobe Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 year after acute myocardial infarction Am J Physiol Heart Circ Physiol 293 2007 H48 H59
20. N.G. Abraham, and A. Kappas Pharmacological and clinical aspects of heme oxygenase Pharmacol Rev 60 2008 79 127
21. R. Gozzelino, V. Jeney, and M.P. Soares Mechanisms of cell protection by heme oxygenase-1 Annu Rev Pharmacol Toxicol 50 2010 323 354
22. J.A. Thomson, J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, and V.S. Marshall Embryonic stem cell lines derived from human blastocysts Science 282 1998 1145 1147
23. J.C. Chachques, B. Cattadori, J. Herreros, F. Prosper, J.C. Trainini, and D. Blanchard Treatment of heart failure with autologous skeletal myoblasts Herz 27 2002 570 578
24. Y. Akamatsu, M. Haga, S. Tyagi, K. Yamashita, A.V. Graca-Souza, and R. Ollinger Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury FASEB J 18 2004 771 772
25. P. Lakkisto, V. Kyto, H. Forsten, J.M. Siren, H. Segersvard, and L.M. Voipio-Pulkki Heme oxygenase-1 and carbon monoxide promote neovascularization after myocardial infarction by modulating the expression of HIF-1alpha, SDF-1alpha and VEGF-B Eur J Pharmacol 635 2010 156 164
26. M. Katori, R. Buelow, B. Ke, J. Ma, A.J. Coito, and S. Iyer Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptotic pathway Transplantation 73 2002 287 292
27. A. L'Abbate, D. Neglia, C. Vecoli, M. Novelli, V. Ottaviano, and S. Baldi Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats Am J Physiol Heart Circ Physiol 293 2007 H3532 H3541
28. E. Negroni, I. Riederer, S. Chaouch, M. Belicchi, P. Razini, and J. Di Santo In vivo myogenic potential of human CD133(+) muscle-derived stem cells: a quantitative study Mol Ther 17 2009 1771 1778
29. M.A. Pfeffer, J.M. Pfeffer, M.C. Fishbein, P.J. Fletcher, J. Spadaro, and R.A. Kloner Myocardial infarct size and ventricular function in rats Circ Res 44 1979 503 512
30. J. Takagawa, Y. Zhang, M.L. Wong, R.E. Sievers, N.K. Kapasi, and Y. Wang Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches J Appl Physiol (1985) 102 2007 2104 2111
31. M.C. Fishbein, D. Maclean, and P.R. Maroko Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution Am J Pathol 90 1978 57 70
32. W. Dai, L.E. Wold, J.S. Dow, and R.A. Kloner Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction J Am Coll Cardiol 46 2005 714 719
33. N.M. Laird, and J.H. Ware Random-effects models for longitudinal data Biometrics 38 1982 963 974
34. P. Lakkisto, J.M. Siren, V. Kyto, H. Forsten, M. Laine, and K. Pulkki Heme oxygenase-1 induction protects the heart and modulates cellular and extracellular remodelling after myocardial infarction in rats Exp Biol Med (Maywood) 236 2011 1437 1448
35. J.J. Chong, X. Yang, C.W. Don, E. Minami, Y.W. Liu, and J.J. Weyers Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts Nature 510 2014 273 277